Concepedia

Joann Wentland

JW

Statistics

Publications

7

Citations

180

H-Index

7

Active since

1999

Affiliations

Pfizer (United States)(Current)

Joann Wentland is an author at Pfizer (United States) specializing in pharmacology, pharmacy, and antibody-drug conjugates.

Publications per year

1999–2017

7

Publications

7

A Priori Prediction of Tumor Payload Concentrations: Preclinical Case Study with an Auristatin-Based Anti-5T4 Antibody-Drug Conjugate

Dhaval K. Shah, Lindsay E. King, Xiaogang Han et al. · The AAPS Journal · 2014 · 60 citations · Full text

, , +17

Biodistribution and Targeting of Anti-5T4 Antibody–Drug Conjugate Using Fluorescence Molecular Tomography

Anand Giddabasappa, Vijay Gupta, Rand Norberg et al. · Molecular Cancer Therapeutics · 2016 · 34 citations

, , +17

Preclinical Development of an anti-5T4 Antibody–Drug Conjugate: Pharmacokinetics in Mice, Rats, and NHP and Tumor/Tissue Distribution in Mice

Mauricio Leal, Joann Wentland, Xiaogang Han et al. · Bioconjugate Chemistry · 2015 · 28 citations

, , +17

Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab Platform

Tracey Clark, Phillip D. Yates, Allison G. Chunyk et al. · The AAPS Journal · 2016 · 19 citations

, , +10

Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptor antagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites

Anne E. Reed‐Hagen, Megumi Tsuchiya, Kaoru Shimada et al. · Biopharmaceutics & Drug Disposition · 1999 · 18 citations

, , +14

1–5 of 7